These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa. Martinez M; Gonçalves S; Felício MR; Maturana P; Santos NC; Semorile L; Hollmann A; Maffía PC Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1329-1337. PubMed ID: 31095945 [TBL] [Abstract][Full Text] [Related]
3. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Dosler S; Karaaslan E Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879 [TBL] [Abstract][Full Text] [Related]
4. Synergistic and antibiofilm properties of ocellatin peptides against multidrug-resistant Pseudomonas aeruginosa. Bessa LJ; Eaton P; Dematei A; Plácido A; Vale N; Gomes P; Delerue-Matos C; Sa Leite JR; Gameiro P Future Microbiol; 2018 Feb; 13():151-163. PubMed ID: 29308671 [TBL] [Abstract][Full Text] [Related]
5. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model. Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms. Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536 [TBL] [Abstract][Full Text] [Related]
7. Evaluation in vitro of the efficacy of colistin methanesulfonate against biofilm-forming multidrug-resistant Pseudomonas aeruginosa (MDRP). Marumo K; Komukai D; Hirose M; Nakamura H; Tanaka H; Ugajin K; Nagashima G; Yoshimura A J Infect Chemother; 2013 Apr; 19(2):348-51. PubMed ID: 22872187 [TBL] [Abstract][Full Text] [Related]
8. Potent effects of amino acid scanned antimicrobial peptide Feleucin-K3 analogs against both multidrug-resistant strains and biofilms of Pseudomonas aeruginosa. Xie J; Li Y; Li J; Yan Z; Wang D; Guo X; Zhang J; Zhang B; Mou L; Yang W; Jiang X Amino Acids; 2018 Oct; 50(10):1471-1483. PubMed ID: 30136030 [TBL] [Abstract][Full Text] [Related]
10. In vitro antimicrobial activity of imipenem plus amikacin or polymyxin B against carbapenem-resistant Pseudomonas aeruginosa isolates. Wilhelm CM; Nunes LS; Martins AF; Barth AL Diagn Microbiol Infect Dis; 2018 Oct; 92(2):152-154. PubMed ID: 29891185 [TBL] [Abstract][Full Text] [Related]
11. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients. Sans-Serramitjana E; Fusté E; Martínez-Garriga B; Merlos A; Pastor M; Pedraz JL; Esquisabel A; Bachiller D; Vinuesa T; Viñas M J Cyst Fibros; 2016 Sep; 15(5):611-8. PubMed ID: 26708265 [TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling. Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains. Kádár B; Szász M; Kristóf K; Pesti N; Krizsán G; Szentandrássy J; Rókusz L; Nagy K; Szabó D Acta Microbiol Immunol Hung; 2010 Sep; 57(3):235-45. PubMed ID: 20870595 [TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa]. Tasaka K; Ishida A; Chinzei T Jpn J Antibiot; 2002 Apr; 55(2):181-6. PubMed ID: 12071095 [TBL] [Abstract][Full Text] [Related]
16. The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum. Maisetta G; Grassi L; Esin S; Serra I; Scorciapino MA; Rinaldi AC; Batoni G Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926942 [No Abstract] [Full Text] [Related]
17. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa. Hu YF; Liu CP; Wang NY; Shih SC BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962 [TBL] [Abstract][Full Text] [Related]
18. Anti-Biofilm Effects of Synthetic Antimicrobial Peptides Against Drug-Resistant Park SC; Lee MY; Kim JY; Kim H; Jung M; Shin MK; Lee WK; Cheong GW; Lee JR; Jang MK Molecules; 2019 Dec; 24(24):. PubMed ID: 31842508 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline. Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309 [TBL] [Abstract][Full Text] [Related]
20. Detection of outer membrane porin protein, an imipenem influx channel, in Pseudomonas aeruginosa clinical isolates. Naenna P; Noisumdaeng P; Pongpech P; Tribuddharat C Southeast Asian J Trop Med Public Health; 2010 May; 41(3):614-24. PubMed ID: 20578550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]